Conflicts of Interest Disclosure : Securities, Mutual Funds, Investments
Scott Garrett reported the following investments:
Investment | Type | Value |
---|---|---|
Bank of the James | Stock | $5,001 to $50,000 |
British American Tobacco | Stock | $50,001 - $250,000 |
Compass Bank | Stock | $5,001 to $50,000 |
Emerson Electric (EMR) | Stock | $50,001 - $250,000 |
Fidus Investment Corp | Stock | $50,001 - $250,000 |
General Electric (GE) | Stock | $50,001 - $250,000 |
GlaxoSmithKline | Stock | $50,001 - $250,000 |
Global Medical | Stock | $5,001 to $50,000 |
IBM | Stock | $50,001 - $250,000 |
Lowes | Stock | More than $250,000 |
McDonald's | Stock | More than $250,000 |
Mesabi Trust | Stock | More than $250,000 |
Mylan Laboratories Inc | Stock | More than $250,000 |
Nuveen | Stock | $50,001 - $250,000 |
Omnicell | Stock | $50,001 - $250,000 |
Pepsi-Cola Co | Stock | $50,001 - $250,000 |
Pfizer Inc | Stock | $50,001 - $250,000 |
Procter & Gamble | Stock | $50,001 - $250,000 |
Scott & Stringfellow | Stock | More than $250,000 |
Triangle Capital | Stock | $50,001 - $250,000 |
WalMart Stores Inc (WMT) | Stock | $50,001 - $250,000 |
Weyerhaeuser (WY) | Stock | $50,001 - $250,000 |
XCEL Energy Corp (XEL) | Stock | $50,001 - $250,000 |